This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Clearview AI faces existential risk as US judge prepares to weigh privacy settlement

By Mike Swift ( January 24, 2025, 01:06 GMT | Comment) -- Clearview AI faces what could be a day of reckoning in a federal court hearing next week as the controversial facial recognition company asks a judge to sign off on a novel privacy litigation settlement plan: to sell off 23 percent of its IPO value to settle class-action allegations, even as nearly two dozen states and a group of objectors call the proposal inadequate. Clearview argues that it is the largest US financial privacy settlement, as a share of a company’s value, in history.Clearview AI, the controversial facial-recognition startup that created a searchable database of billions of faces scraped from the Internet, faces what could be an existential moment next week as it asks a federal judge to bless a novel privacy settlement. In it, Clearview would sell off nearly a quarter of its initial stock offering value to consumers....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login